The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis
Top Cited Papers
- 1 February 2004
- journal article
- research article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 30 (1), 83-101
- https://doi.org/10.1016/j.ctrv.2003.07.004
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Metastasis in Soft Tissue Sarcomas: Prognostic Criteria and Treatment PerspectivesCancer and Metastasis Reviews, 2002
- Role of Repeated F-18 Fluorodeoxyglucose Imaging in Management of Patients with Bone and Soft Tissue SarcomaCancer Biotherapy & Radiopharmaceuticals, 2001
- Publications on diagnostic test evaluation in family medicine journals: an optimal search strategyJournal of Clinical Epidemiology, 2000
- Epidemiological aspects of soft tissue sarcomas (STS)—consequences for the design of clinical STS trialsEuropean Journal Of Cancer, 1999
- A PET study of 18 FDG uptake in soft tissue massesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucoseAnnals of Surgical Oncology, 1997
- Developing Optimal Search Strategies for Detecting Clinically Sound Studies in MEDLINEJournal of the American Medical Informatics Association, 1994
- Patterns of metastatic spread following resection of extremity soft‐tissue sarcomas and strategies for treatmentSeminars in Surgical Oncology, 1988
- Adult Soft Tissue SarcomasAnnals of Surgery, 1987
- Patterns of recurrence in patients with high-grade soft-tissue sarcomas.Journal of Clinical Oncology, 1985